No results for ‘’
Astec Lifesciences Ltd
₹797.70
(0.48%)
Wed, 24 Jun 2026, 10:01 am
Process Industries
Chemicals: Agricultural
24.5KAstec Lifesciences Enterprise Value (EV)
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 4.47 | 15.92 | 36.30 | 4.93 | 7.85 | 19.38 | 76.77 | 61.70 | 32.61 | 29.50 | 16.48 | 30.12 | 38.22 | 106.03 | 0 | 0 |
| Price to book ratio | 0 | 0.89 | 0.80 | 0.51 | 0.29 | 0.60 | 2.11 | 3.21 | 8.53 | 6.70 | 5.20 | 3.17 | 6.34 | 8.66 | 6.46 | 5.64 | 5.64 |
| Price to sales ratio | 0 | 0.53 | 0.71 | 0.44 | 0.17 | 0.33 | 1.08 | 1.66 | 4 | 3.15 | 2.45 | 1.50 | 3.53 | 5.08 | 4.32 | 4.54 | 3.48 |
| Price to cash flow ratio | 0 | 8.73 | 5.57 | 10.58 | 2.83 | 6.67 | 47.32 | 0 | 159.69 | 20.87 | 322.19 | 5.03 | 0 | 228.64 | 46.20 | 0 | 0 |
| Enterprise value | 0 | 94.1Cr | 119Cr | 106Cr | 93.86Cr | 146Cr | 373Cr | 501Cr | 1301Cr | 1261Cr | 1229Cr | 880Cr | 2145Cr | 3712Cr | 3050Cr | 2574Cr | 1875Cr |
| Enterprise value to EBITDA ratio | 0 | 3.69 | 7.55 | 6.27 | 3.26 | 3.95 | 6.84 | 14.54 | 20.72 | 20.02 | 15.60 | 10.18 | 19.04 | 23.88 | 38.77 | 0 | 0 |
| Debt to equity ratio | 1.36 | 0.40 | 0.45 | 0.73 | 0.66 | 0.73 | 0.73 | 1.08 | 0.92 | 0.73 | 0.87 | 0.40 | 0.61 | 0.70 | 0.81 | 1.34 | 2.36 |
| Return on equity % | 0 | 21.11 | 5.17 | 1.40 | 5.83 | 7.91 | 11.88 | 3.92 | 15 | 22.69 | 19.21 | 21.16 | 23.41 | 25.47 | 6.26 | -11.89 | -44.61 |
Astec Lifesciences Ltd Enterprise Value
The Astec Lifesciences Ltd Enterprise Value is a key financial metric used by investors to evaluate Astec Lifesciences Ltd's valuation, profitability, and overall financial performance. Tracking the Astec Lifesciences Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Astec Lifesciences Ltd (NSE: ASTEC, BSE: 533138) is currently trading at ₹797.70, with a market capitalization of ₹1776.16Cr. As a leading company in the Process industries sector and Chemicals: agricultural industry, monitoring the Astec Lifesciences Ltd Enterprise Value is essential for fundamental analysis.
Astec Lifesciences Ltd Enterprise Value Current Value
The current Astec Lifesciences Ltd Enterprise Value stands at 1875Cr.
The Astec Lifesciences Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
Astec Lifesciences Ltd Enterprise Value Historical Trend
The Astec Lifesciences Ltd Enterprise Value has shown the following historical trend:
- 2024: 1875Cr
- 2023: 2574Cr
- 2022: 3050Cr
- 2021: 3712Cr
- 2020: 2145Cr
The decline in Astec Lifesciences Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What Astec Lifesciences Ltd Enterprise Value Indicates for Investors
The Astec Lifesciences Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of Astec Lifesciences Ltd.
Astec Lifesciences Ltd Enterprise Value Analysis Summary
The Astec Lifesciences Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Astec Lifesciences Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Astec Lifesciences Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.